Role of Ginkgo Biloba Extract in IUGR
关键词
抽象
日期
最后验证: | 02/29/2016 |
首次提交: | 04/20/2015 |
提交的预估入学人数: | 04/22/2015 |
首次发布: | 04/23/2015 |
上次提交的更新: | 03/19/2016 |
最近更新发布: | 03/21/2016 |
实际学习开始日期: | 04/30/2014 |
预计主要完成日期: | 09/30/2015 |
预计完成日期: | 11/30/2015 |
状况或疾病
干预/治疗
Drug: Ginkgo Biloba Extract group
Other: Placebo group
相
手臂组
臂 | 干预/治疗 |
---|---|
Active Comparator: Ginkgo Biloba Extract group This group received Ginko Biloba, two tablets per day | Drug: Ginkgo Biloba Extract group |
Placebo Comparator: Placebo group This group received placebo two tablets per day . | Other: Placebo group |
资格标准
有资格学习的年龄 | 20 Years 至 20 Years |
有资格学习的性别 | Female |
接受健康志愿者 | 是 |
标准 | Inclusion Criteria: - Pregnant women in their third trimester (28-30 weeks of gestation). - Pregnant women whose pregnancy was complicated with intra uterine growth restriction (IUGR). - Normal Doppler indices in uterine, umbilical and middle cerebral arteries at time of recruitment. Exclusion Criteria: - Multiple pregnancies, - Hypertension, - Fetal congenital anomalies, - Previous history of congenital anomalies or chromosomal abnormalities. - Diabetes Mellitus - Premature pre-labor rupture of membranes - Antepartum hemorrhage |
结果
主要结果指标
1. Fetal weight (gm) [one and half year]
次要成果指标
1. Doppler blood flow changes in uterine arteries indices [one and half year]
2. Doppler blood flow changes in umbilical arteries indices [one and half year]
3. Doppler blood flow changes in middle cerebral artery indices [one and half year]